Canaccord Genuity Starts ANI Pharmaceuticals (ANIP) at Buy
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $75.35 --0%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 56
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 56
Join SI Premium – FREE
Canaccord Genuity initiates coverage on ANI Pharmaceuticals (NASDAQ: ANIP) with a Buy rating and a price target of $60.00.
Analyst Dewey Steadman with the coverage.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $48.64 Friday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
- Cantor Fitzgerald Starts Nuvectis Pharma (NVCT) at Overweight
- Wells Fargo Starts Fortune Brands (FBIN) at Overweight, 'Catch Up Potential Could Prove Attractive (with Caveats)'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
